Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 26Multiple Myeloma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia 19Lymphoma 18Hodgkin Disease 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Lymphoma, Non-Hodgkin 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Large B-Cell, Diffuse 10Hematologic Neoplasms 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Chronic 8Graft vs Host Disease 8Myeloproliferative Disorders 7Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Leukemia, Myelomonocytic, Juvenile 5Recurrence 4Neoplasms 4Lymphoma, T-Cell 4Lymphoma, B-Cell, Marginal Zone 4Burkitt Lymphoma 4Breast Neoplasms 4Anemia, Aplastic 4Polycythemia Vera 3Lymphoma, Mantle-Cell 3Leukemia, Biphenotypic, Acute 3Hemoglobinuria, Paroxysmal 3

Interventions

Paclitaxel 134Carboplatin 129Bevacizumab 86Gemcitabine 45pembrolizumab 37olaparib 33Cisplatin 30liposomal doxorubicin 29Docetaxel 29Cyclophosphamide 29Topotecan 28niraparib 27Taxes 20Etoposide 18Filgrastim 16Doxorubicin 16Immunoglobulin G 15Disulfides 15apatinib 12Letrozole 12Albumin-Bound Paclitaxel 12Drug Therapy 11fluzoparib 10fludarabine 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Biopsy 10durvalumab 9Nivolumab 9pazopanib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Neoplasms × Stem Cell Transplantation × Clear all
NCT00583622 2013-05-21

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Terminated
13 enrolled 5 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡